Screener
Revolution Medicines, Inc. RVMD Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ComprehensiveIncomeNetOfTax.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:10 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335104
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net loss per share attributable to common stockholders, basic and diluted | $(3.06) | $(1.31) | (5.37) | $(2.45) |
| Weighted-average common shares used to compute net loss per share, basic and diluted | 210,893,604 | 188,583,288 | 204,531,173 | 188,365,805 |
| Comprehensive loss: | ||||
| Net loss | $(644,371) | $(247,787) | $(1,098,187) | $(461,203) |
| Other comprehensive loss: | ||||
| Foreign currency translation adjustments | (93) | — | (101) | — |
| Unrealized loss on investments, net | (5,235) | (405) | (9,086) | (19) |
| Comprehensive loss | $(649,699) | $(248,192) | $(1,107,374) | $(461,222) |
Item 1. Financial Statements.
FAQ
- What is Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Revolution Medicines, Inc. (RVMD) reported comprehensive income (loss), net of tax, attributable to parent of -$649.7M in Q2 2026.
- How has Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent changed year-over-year?
- Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent decreased by 161.8% year-over-year, from -$248.19M to -$649.7M.
- What is the long-term trend for Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent has grown at a 56.6% compound annual growth rate (CAGR), from -$187.58M to -$1.13B.
- What does comprehensive income (loss), net of tax, attributable to parent mean?
- This metric represents the total change in equity from non-owner sources, encompassing both net income and other comprehensive income items like unrealized gains or losses on securities. It provides a comprehensive view of the company's total financial performance and changes in net worth during a specific period. Investors use this to assess the broader economic impact on shareholder value beyond traditional net income.
Ask your AI about Revolution Medicines, Inc.'s comprehensive income (loss), net of tax, attributable to parent.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude